©2021 Business Next Media Corp. All Rights Reserved. 106 台北市大安區光復南路102號9樓
Too fast! too good! MobioSense's new covid-19 diagnostic kit can skyrocket the efficiency of testing
Taiwan’s startup MobioSense team up with Kaohsiung Medical University, developed Taiwan’s first “COVID-19 Isothermal Nucleic Acid Diagnostic Kit.” It can tremendously increase the testing speed
The Covid-19 pandemic severely impacted the economy around the world in 2020, and we still do not see a stop sign on this pandemic, Moreover, the Covid-19 cases just cumulate faster and faster especially in the US and Europe. The US government also announced that all the international airline passengers will need to show proof of a negative Covid-19 test before boarding the flights to US soil.
With the strong Covid-19 testing need from the US, MobioSense is actively cooperating with US health-related institutions like Harvard Medical School, Healthcare Transformation Lab and the University of Florida, hoping to accelerate the pace to go to the US market. MobioSense Covid-19 testing kits expect to do the clinical trial with the University of Florida this year.
The most popular Covid-19 testing method for people now is using the real-time polymerase chain reaction (real-time PCR) technique, also known as quantitative Polymerase Chain Reaction (qPCR), which detects the amplification of a targeted DNA to test the virus concentration.
This traditional testing method needs to take one and a half hours per person to check the result, and it is hard to meet the testing demand given the rapidly-increased positive cases. Moreover, most of the qPCR methods can not detect the new Covid-19 variant.
MobioSense’s testing kits is based on isothermal nucleic acid amplification technique that can reduce the testing time to 20 mintues per person, five times faster compared to traditional qPCR method. And it is also compatiable with the current qPCR testing machine, making it so the hospital and laboratory can easily adopt MobioSense’s diagnostic kit.
For fighting Covid-19, Taiwan Food and Drug Administration launched a special project to quickly approve MobioSense to maunfacture diagnostic kits. In the same time, MobioSense is in the process of applying the FDA approval to distribute the diagnostic kits in the US.
©2021 Business Next Media Corp. All Rights Reserved. 106 台北市大安區光復南路102號9樓